製品の概要

  • 製品名Anti-Fibrillin 1 antibody [11C1.3] (Biotin)
    Fibrillin 1 一次抗体 製品一覧
  • 製品の詳細
    Mouse monoclonal [11C1.3] to Fibrillin 1 (Biotin)
  • 標識Biotin
  • 特異性This antibody recognises fibrillin (Mr 350 kDa).
  • アプリケーション適用あり: IHC-Fr, IHC-P, ICC/IF, Electron Microscopy, WBmore details
  • 種交差性
    交差種: Cow, Human
  • 免疫原

    Microfibrils from zonular apparatus of bovine eye.

製品の特性

  • 製品の状態Liquid
  • 保存方法Shipped at 4°C. Store at +4°C short term (1-2 weeks). Store at -20°C or -80°C. Avoid freeze / thaw cycle.
  • バッファーPreservative: 0.1% Sodium Azide
    Constituents: PBS
  • Concentration information loading...
  • 精製度IgG fraction
  • ポリ/モノモノクローナル
  • クローン名11C1.3
  • アイソタイプIgG1
  • 軽鎖の種類kappa
  • 研究分野

アプリケーション

Our Abpromise guarantee covers the use of ab24826 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

アプリケーション Abreviews 特記事項
IHC-Fr
IHC-P
ICC/IF
Electron Microscopy
WB
  • 追加情報Electron Microscopy: Use at an assay dependent dilution.
    IF: Use at an assay dependent dilution.
    IHC-P: 1/200. Perform heat mediated antigen retrieval via the microwave/citrate buffer method before commencing with IHC staining protocol.
    IHC-Fr: 1/200 - 1/500.
    WB: Use at a concentration of 1 µg/ml. Predicted molecular weight: 312 kDa.


    Not yet tested in other applications.
    Optimal dilutions/concentrations should be determined by the end user.
  • ターゲット情報

    • 機能Fibrillins are structural components of 10-12 nm extracellular calcium-binding microfibrils, which occur either in association with elastin or in elastin-free bundles. Fibrillin-1-containing microfibrils provide long-term force bearing structural support. Regulates osteoblast maturation by controlling TGF-beta bioavailability and calibrating TGF-beta and BMP levels, respectively.
    • 関連疾患Defects in FBN1 are a cause of Marfan syndrome (MFS) [MIM:154700]. MFS is an autosomal dominant disorder that affects the skeletal, ocular, and cardiovascular systems. A wide variety of skeletal abnormalities occurs with MFS, including scoliosis, chest wall deformity, tall stature, abnormal joint mobility. Ectopia lentis occurs in up to about 80% of MFS patients and is almost always bilateral. The leading cause of premature death in MFS patients is progressive dilation of the aortic root and ascending aorta, causing aortic incompetence and dissection. Note=The majority of the more than 600 mutations in FBN1 currently known are point mutations, the rest are frameshifts and splice site mutations. Marfan syndrome has been suggested in at least 2 historical figures, Abraham Lincoln and Paganini.
      Defects in FBN1 are a cause of isolated ectopia lentis (EL) [MIM:129600]. The symptoms of this autosomal dominant fibrillinopathy overlap with those of Marfan syndrome, with the exclusion of the skeletal and cardiovascular manifestations.
      Defects in FBN1 are the cause of Weill-Marchesani syndrome autosomal dominant (ADWMS) [MIM:608328]. A rare connective tissue disorder characterized by short stature, brachydactyly, joint stiffness, and eye abnormalities including microspherophakia, ectopia lentis, severe myopia and glaucoma.
      Defects in FBN1 are a cause of Shprintzen-Goldberg craniosynostosis syndrome (SGS) [MIM:182212]. SGS is a very rare syndrome characterized by a marfanoid habitus, craniosynostosis, characteristic dysmorphic facial features, skeletal and cardiovascular abnormalities, mental retardation, developmental delay and learning disabilities.
      Defects in FBN1 are a cause of overlap connective tissue disease (OCTD) [MIM:604308]. A heritable disorder of connective tissue characterized by involvement of the mitral valve, aorta, skeleton, and skin. MASS syndrome is closely resembling both the Marfan syndrome and the Barlow syndrome. However, no dislocation of the lenses or aneurysmal changes occur in the aorta, and the mitral valve prolapse is by no means invariable.
      Defects in FBN1 are a cause of stiff skin syndrome (SSKS) [MIM:184900]. It is a syndrome characterized by hard, thick skin, usually over the entire body, which limits joint mobility and causes flexion contractures. Other occasional findings include lipodystrophy and muscle weakness.
    • 配列類似性Belongs to the fibrillin family.
      Contains 47 EGF-like domains.
      Contains 9 TB (TGF-beta binding) domains.
    • 翻訳後修飾Forms intermolecular disulfide bonds either with other fibrillin-1 molecules or with other components of the microfibrils.
    • 細胞内局在Secreted > extracellular space > extracellular matrix.
    • Information by UniProt
    • 参照データベース
    • 別名
      • 350 kDa glycoprotein component extracellular microfibril antibody
      • ACMICD antibody
      • FBN 1 antibody
      • FBN antibody
      • FBN1 antibody
      • FBN1_HUMAN antibody
      • Fibrillin 15 antibody
      • Fibrillin-1 antibody
      • Fibrillin1 antibody
      • Fibrillin15 antibody
      • GPHYSD2 antibody
      • Marfan syndrome antibody
      • MASS antibody
      • MFS 1 antibody
      • MFS1 antibody
      • OCTD antibody
      • SGS antibody
      • SSKS antibody
      • Weill Marchesani syndrome antibody
      • WMS antibody
      • WMS2 antibody
      see all

    Anti-Fibrillin 1 antibody [11C1.3] (Biotin) (ab24826) 使用論文

    This product has been referenced in:
    • Maier A  et al. Fibrillin and elastin networks in extrafusal tissue and muscle spindles of bovine extraocular muscles. Invest Ophthalmol Vis Sci 35:3103-10 (1994). Read more (PubMed: 8206729) »
    • Wright DW  et al. Immunization with undenatured bovine zonular fibrils results in monoclonal antibodies to fibrillin. Matrix Biol 14:41-9 (1994). Read more (PubMed: 8061919) »

    See all 2 Publications for this product

    Product Wall

    There are currently no Abreviews or Questions for ab24826.
    Please use the links above to contact us or submit feedback about this product.

    Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"